RelB expression was previously described to be elevated in the aggressive mesenchymal glioma subtype [26] and we have recently identified a functional role for RelB as a key driver of mesenchymal gene expression and tumorigenesis [17]. This evidence concerns the gene RELB and central nervous system cancer.